CN Stock MarketDetailed Quotes

300519 Zhejiang Xinguang Pharmaceutical

Watchlist

14.55
+0.04+0.28%

Market Closed Nov 4 15:00 CST

2.33BMarket Cap53.69P/E (TTM)

Zhejiang Xinguang Pharmaceutical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Assets

Current assets

Money funds

-29.73%424.61M

-13.83%470.55M

-4.50%595.84M

-12.55%543.95M

0.78%604.27M

-5.27%546.07M

2.43%623.93M

4.78%622.03M

8.01%599.61M

16.13%576.43M

Transactional financial assets

172.22%245M

35.71%190M

0.00%140M

34.78%155M

-14.29%90M

33.33%140M

-12.50%140M

-8.00%115M

-12.50%105M

-25.00%105M

Notes receivable and accounts receivable

3.29%17.01M

-15.58%10.12M

-6.80%7.75M

-58.04%9.99M

-23.89%16.47M

-14.58%11.99M

-14.92%8.32M

49.50%23.81M

-2.27%21.64M

-11.83%14.03M

-Accounts receivable

3.29%17.01M

-15.58%10.12M

-6.80%7.75M

-58.04%9.99M

-23.89%16.47M

-14.58%11.99M

-14.92%8.32M

49.50%23.81M

-2.27%21.64M

-11.83%14.03M

Other receivables (including interest and dividends)

-65.08%66.82K

-55.01%100.37K

1,416.23%130.28K

360.38%180.19K

183.61%191.35K

132.62%223.1K

-93.45%8.59K

-75.73%39.14K

-64.51%67.47K

-56.43%95.91K

-Other receivable

----

-55.01%100.37K

----

132.62%223.1K

----

-75.73%39.14K

----

-56.43%95.91K

Advance payment

-2.75%3.62M

7.27%2.52M

-37.77%3.59M

-4.92%2.43M

0.44%3.72M

19.71%2.35M

62.00%5.76M

6.43%2.55M

6.45%3.7M

-16.50%1.96M

Inventories

2.91%61.7M

19.21%63.69M

27.49%50.34M

54.76%71.42M

32.59%59.96M

6.47%53.43M

-9.86%39.48M

-1.31%46.15M

24.53%45.22M

26.67%50.18M

Receivable financing

-45.42%707.6K

18.95%721.73K

75.59%1.05M

-55.35%748.36K

27.19%1.3M

-12.36%606.74K

-30.56%596.26K

5.79%1.68M

7.88%1.02M

13.65%692.31K

Other current assets

-42.46%946.23K

17.37%1.34M

5.76%1.16M

43.96%1.46M

--1.64M

6,109.81%1.14M

666.03%1.1M

141.59%1.01M

----

-81.78%18.38K

Total current assets

-3.07%753.66M

-2.22%739.04M

-2.36%799.85M

-3.34%785.17M

0.17%777.54M

0.99%755.81M

-0.99%819.19M

3.35%812.26M

5.12%776.25M

7.66%748.41M

Non Current assets

Other equity investment

2.57%21.42M

1.72%21.12M

1.88%20.92M

5.02%21.4M

3.46%20.88M

1.11%20.77M

-1.22%20.53M

-0.82%20.37M

-6.06%20.18M

-10.25%20.54M

Investment real estate

----

-19.75%22.94K

-26.32%23.06K

-31.84%23.17K

-29.49%25.88K

-27.46%28.58K

-25.70%31.29K

Fixed assets

----

3.95%112.61M

----

0.15%108.33M

----

9.30%112.94M

----

-1.70%108.17M

Constru in process

----

-97.06%43.6K

----

-88.82%1.48M

----

-82.87%1.95M

----

614.85%13.27M

Intangible assets

-5.76%7.95M

-7.99%8.02M

-10.07%8.09M

-12.02%8.17M

-11.82%8.43M

-11.48%8.72M

-11.16%9M

-10.86%9.28M

-10.57%9.57M

-10.30%9.85M

Deferred tax assets

-65.61%293.37K

-75.44%197.85K

-65.29%258.6K

-78.20%203.28K

-6.89%853.1K

-5.95%805.67K

2.65%745K

13.50%932.51K

10.47%916.18K

11.12%856.65K

Total non current assets

-2.07%138.79M

1.34%142M

1.31%144.86M

-0.18%145.24M

-5.10%141.73M

-8.24%140.13M

-5.76%142.99M

-0.68%145.5M

-0.33%149.34M

0.06%152.71M

Total assets

-2.92%892.45M

-1.66%881.04M

-1.81%944.72M

-2.86%930.41M

-0.68%919.27M

-0.58%895.93M

-1.73%962.18M

2.72%957.76M

4.20%925.6M

6.29%901.12M

Liabilities

Current liabilities

Notes payable and accounts payable

-7.71%55.29M

9.77%62.74M

25.32%60.82M

12.56%63.88M

25.56%59.91M

7.65%57.15M

-11.75%48.53M

1.13%56.75M

9.50%47.71M

37.67%53.09M

-Accounts payable

-7.71%55.29M

9.77%62.74M

25.32%60.82M

12.56%63.88M

25.56%59.91M

7.65%57.15M

-11.75%48.53M

1.13%56.75M

9.50%47.71M

37.67%53.09M

Contract liabilities

50.25%363.75K

-80.12%666.71K

748.58%2.72M

8.75%157.19K

-14.57%242.09K

395.24%3.35M

-86.95%321.1K

64.37%144.55K

-19.03%283.39K

155.98%677.28K

Advance receipts

----

--1.73M

----

Salaries payable

6.58%729.77K

6.77%660.14K

7.94%595.33K

-16.93%4.03M

-21.57%684.73K

-2.24%618.29K

-5.29%551.54K

-1.32%4.85M

31.92%873.09K

7.18%632.44K

Taxs payable

-17.06%7.94M

-70.42%1.56M

-62.14%3.99M

-79.31%4.77M

-63.08%9.57M

-77.10%5.26M

-47.32%10.54M

103.72%23.03M

111.05%25.91M

203.45%22.98M

Other payable (including interest and dividends)

51.14%1.18M

2.64%1.38M

7.92%814.66K

18.27%4.23M

8.34%779.55K

-12.78%1.35M

0.03%754.87K

28.28%3.58M

-24.27%719.55K

8.02%1.55M

-Other payable

----

2.64%1.38M

----

-12.78%1.35M

----

28.28%3.58M

----

8.02%1.55M

Other current liabilities

50.25%47.29K

-80.12%86.67K

748.58%354.23K

8.75%20.43K

-14.57%31.47K

395.24%436.04K

-86.95%41.74K

64.37%18.79K

--36.84K

--88.05K

Total current liabilities

-7.96%65.54M

-1.58%67.09M

10.93%69.3M

-12.77%77.08M

-5.73%71.21M

-13.72%68.17M

-21.04%62.47M

17.48%88.37M

30.66%75.54M

63.18%79.02M

Current liabilities

Long term account payable

----

0.00%2.36M

----

0.00%2.36M

----

0.00%2.36M

----

0.00%2.36M

Deferred tax liabilities

----

26.32%502.06K

7.60%485.25K

-7.82%449.86K

-5.61%426.23K

-0.84%397.44K

7.73%450.97K

Long term deferred income

-7.54%6.63M

-13.35%6.19M

-12.25%6.52M

-11.23%6.84M

-10.29%7.17M

-13.65%7.14M

-5.86%7.43M

-5.43%7.71M

-5.02%7.99M

-2.21%8.27M

Total non current liabilities

-10.39%8.99M

-14.40%8.55M

-13.28%8.88M

-12.31%9.2M

-6.67%10.03M

-9.88%9.99M

-4.66%10.24M

-4.27%10.5M

-3.81%10.75M

-1.37%11.09M

Total liabilities

-8.26%74.53M

-3.22%75.65M

7.52%78.17M

-12.72%86.29M

-5.85%81.25M

-13.25%78.16M

-19.08%72.7M

14.71%98.86M

25.08%86.29M

51.01%90.1M

Shareholders equity

Paid-in capital

0.00%160M

Capital reserve funds

0.00%161.29M

Surplus reserve funds

6.09%111.92M

11.22%105.5M

13.67%94.86M

Retained profit

-6.61%381.41M

-4.92%369.13M

-6.45%430.45M

-5.14%407.62M

-2.97%408.39M

-1.04%388.23M

-2.17%460.14M

0.51%429.69M

2.09%420.91M

2.97%392.32M

Other composite income

16.05%3.3M

11.05%3.05M

12.89%2.88M

36.01%3.29M

26.32%2.84M

7.60%2.75M

-7.82%2.55M

-5.61%2.42M

-0.84%2.25M

7.73%2.56M

Shareholders equity without minority interests

-2.40%817.92M

-1.51%805.4M

-2.58%866.54M

-1.72%844.12M

-0.15%838.02M

0.83%817.77M

0.03%889.47M

1.50%858.89M

2.44%839.31M

2.90%811.02M

Total shareholder equity

-2.40%817.92M

-1.51%805.4M

-2.58%866.54M

-1.72%844.12M

-0.15%838.02M

0.83%817.77M

0.03%889.47M

1.50%858.89M

2.44%839.31M

2.90%811.02M

Total liabilityies and equity

-2.92%892.45M

-1.66%881.04M

-1.81%944.72M

-2.86%930.41M

-0.68%919.27M

-0.58%895.93M

-1.73%962.18M

2.72%957.76M

4.20%925.6M

6.29%901.12M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Tianjian Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Assets
Current assets
Money funds	-29.73%424.61M	-13.83%470.55M	-4.50%595.84M	-12.55%543.95M	0.78%604.27M	-5.27%546.07M	2.43%623.93M	4.78%622.03M	8.01%599.61M	16.13%576.43M
Transactional financial assets	172.22%245M	35.71%190M	0.00%140M	34.78%155M	-14.29%90M	33.33%140M	-12.50%140M	-8.00%115M	-12.50%105M	-25.00%105M
Notes receivable and accounts receivable	3.29%17.01M	-15.58%10.12M	-6.80%7.75M	-58.04%9.99M	-23.89%16.47M	-14.58%11.99M	-14.92%8.32M	49.50%23.81M	-2.27%21.64M	-11.83%14.03M
-Accounts receivable	3.29%17.01M	-15.58%10.12M	-6.80%7.75M	-58.04%9.99M	-23.89%16.47M	-14.58%11.99M	-14.92%8.32M	49.50%23.81M	-2.27%21.64M	-11.83%14.03M
Other receivables (including interest and dividends)	-65.08%66.82K	-55.01%100.37K	1,416.23%130.28K	360.38%180.19K	183.61%191.35K	132.62%223.1K	-93.45%8.59K	-75.73%39.14K	-64.51%67.47K	-56.43%95.91K
-Other receivable	----	-55.01%100.37K	----	----	----	132.62%223.1K	----	-75.73%39.14K	----	-56.43%95.91K
Advance payment	-2.75%3.62M	7.27%2.52M	-37.77%3.59M	-4.92%2.43M	0.44%3.72M	19.71%2.35M	62.00%5.76M	6.43%2.55M	6.45%3.7M	-16.50%1.96M
Inventories	2.91%61.7M	19.21%63.69M	27.49%50.34M	54.76%71.42M	32.59%59.96M	6.47%53.43M	-9.86%39.48M	-1.31%46.15M	24.53%45.22M	26.67%50.18M
Receivable financing	-45.42%707.6K	18.95%721.73K	75.59%1.05M	-55.35%748.36K	27.19%1.3M	-12.36%606.74K	-30.56%596.26K	5.79%1.68M	7.88%1.02M	13.65%692.31K
Other current assets	-42.46%946.23K	17.37%1.34M	5.76%1.16M	43.96%1.46M	--1.64M	6,109.81%1.14M	666.03%1.1M	141.59%1.01M	----	-81.78%18.38K
Total current assets	-3.07%753.66M	-2.22%739.04M	-2.36%799.85M	-3.34%785.17M	0.17%777.54M	0.99%755.81M	-0.99%819.19M	3.35%812.26M	5.12%776.25M	7.66%748.41M
Non Current assets
Other equity investment	2.57%21.42M	1.72%21.12M	1.88%20.92M	5.02%21.4M	3.46%20.88M	1.11%20.77M	-1.22%20.53M	-0.82%20.37M	-6.06%20.18M	-10.25%20.54M
Investment real estate	----	----	----	----	-19.75%22.94K	-26.32%23.06K	-31.84%23.17K	-29.49%25.88K	-27.46%28.58K	-25.70%31.29K
Fixed assets	----	3.95%112.61M	----	----	----	0.15%108.33M	----	9.30%112.94M	----	-1.70%108.17M
Constru in process	----	-97.06%43.6K	----	----	----	-88.82%1.48M	----	-82.87%1.95M	----	614.85%13.27M
Intangible assets	-5.76%7.95M	-7.99%8.02M	-10.07%8.09M	-12.02%8.17M	-11.82%8.43M	-11.48%8.72M	-11.16%9M	-10.86%9.28M	-10.57%9.57M	-10.30%9.85M
Deferred tax assets	-65.61%293.37K	-75.44%197.85K	-65.29%258.6K	-78.20%203.28K	-6.89%853.1K	-5.95%805.67K	2.65%745K	13.50%932.51K	10.47%916.18K	11.12%856.65K
Total non current assets	-2.07%138.79M	1.34%142M	1.31%144.86M	-0.18%145.24M	-5.10%141.73M	-8.24%140.13M	-5.76%142.99M	-0.68%145.5M	-0.33%149.34M	0.06%152.71M
Total assets	-2.92%892.45M	-1.66%881.04M	-1.81%944.72M	-2.86%930.41M	-0.68%919.27M	-0.58%895.93M	-1.73%962.18M	2.72%957.76M	4.20%925.6M	6.29%901.12M
Liabilities
Current liabilities
Notes payable and accounts payable	-7.71%55.29M	9.77%62.74M	25.32%60.82M	12.56%63.88M	25.56%59.91M	7.65%57.15M	-11.75%48.53M	1.13%56.75M	9.50%47.71M	37.67%53.09M
-Accounts payable	-7.71%55.29M	9.77%62.74M	25.32%60.82M	12.56%63.88M	25.56%59.91M	7.65%57.15M	-11.75%48.53M	1.13%56.75M	9.50%47.71M	37.67%53.09M
Contract liabilities	50.25%363.75K	-80.12%666.71K	748.58%2.72M	8.75%157.19K	-14.57%242.09K	395.24%3.35M	-86.95%321.1K	64.37%144.55K	-19.03%283.39K	155.98%677.28K
Advance receipts	----	----	----	----	----	----	--1.73M	----	----	----
Salaries payable	6.58%729.77K	6.77%660.14K	7.94%595.33K	-16.93%4.03M	-21.57%684.73K	-2.24%618.29K	-5.29%551.54K	-1.32%4.85M	31.92%873.09K	7.18%632.44K
Taxs payable	-17.06%7.94M	-70.42%1.56M	-62.14%3.99M	-79.31%4.77M	-63.08%9.57M	-77.10%5.26M	-47.32%10.54M	103.72%23.03M	111.05%25.91M	203.45%22.98M
Other payable (including interest and dividends)	51.14%1.18M	2.64%1.38M	7.92%814.66K	18.27%4.23M	8.34%779.55K	-12.78%1.35M	0.03%754.87K	28.28%3.58M	-24.27%719.55K	8.02%1.55M
-Other payable	----	2.64%1.38M	----	----	----	-12.78%1.35M	----	28.28%3.58M	----	8.02%1.55M
Other current liabilities	50.25%47.29K	-80.12%86.67K	748.58%354.23K	8.75%20.43K	-14.57%31.47K	395.24%436.04K	-86.95%41.74K	64.37%18.79K	--36.84K	--88.05K
Total current liabilities	-7.96%65.54M	-1.58%67.09M	10.93%69.3M	-12.77%77.08M	-5.73%71.21M	-13.72%68.17M	-21.04%62.47M	17.48%88.37M	30.66%75.54M	63.18%79.02M
Current liabilities
Long term account payable	----	0.00%2.36M	----	----	----	0.00%2.36M	----	0.00%2.36M	----	0.00%2.36M
Deferred tax liabilities	----	----	----	----	26.32%502.06K	7.60%485.25K	-7.82%449.86K	-5.61%426.23K	-0.84%397.44K	7.73%450.97K
Long term deferred income	-7.54%6.63M	-13.35%6.19M	-12.25%6.52M	-11.23%6.84M	-10.29%7.17M	-13.65%7.14M	-5.86%7.43M	-5.43%7.71M	-5.02%7.99M	-2.21%8.27M
Total non current liabilities	-10.39%8.99M	-14.40%8.55M	-13.28%8.88M	-12.31%9.2M	-6.67%10.03M	-9.88%9.99M	-4.66%10.24M	-4.27%10.5M	-3.81%10.75M	-1.37%11.09M
Total liabilities	-8.26%74.53M	-3.22%75.65M	7.52%78.17M	-12.72%86.29M	-5.85%81.25M	-13.25%78.16M	-19.08%72.7M	14.71%98.86M	25.08%86.29M	51.01%90.1M
Shareholders equity
Paid-in capital	0.00%160M	0.00%160M	0.00%160M	0.00%160M	0.00%160M	0.00%160M	0.00%160M	0.00%160M	0.00%160M	0.00%160M
Capital reserve funds	0.00%161.29M	0.00%161.29M	0.00%161.29M	0.00%161.29M	0.00%161.29M	0.00%161.29M	0.00%161.29M	0.00%161.29M	0.00%161.29M	0.00%161.29M
Surplus reserve funds	6.09%111.92M	6.09%111.92M	6.09%111.92M	6.09%111.92M	11.22%105.5M	11.22%105.5M	11.22%105.5M	11.22%105.5M	13.67%94.86M	13.67%94.86M
Retained profit	-6.61%381.41M	-4.92%369.13M	-6.45%430.45M	-5.14%407.62M	-2.97%408.39M	-1.04%388.23M	-2.17%460.14M	0.51%429.69M	2.09%420.91M	2.97%392.32M
Other composite income	16.05%3.3M	11.05%3.05M	12.89%2.88M	36.01%3.29M	26.32%2.84M	7.60%2.75M	-7.82%2.55M	-5.61%2.42M	-0.84%2.25M	7.73%2.56M
Shareholders equity without minority interests	-2.40%817.92M	-1.51%805.4M	-2.58%866.54M	-1.72%844.12M	-0.15%838.02M	0.83%817.77M	0.03%889.47M	1.50%858.89M	2.44%839.31M	2.90%811.02M
Total shareholder equity	-2.40%817.92M	-1.51%805.4M	-2.58%866.54M	-1.72%844.12M	-0.15%838.02M	0.83%817.77M	0.03%889.47M	1.50%858.89M	2.44%839.31M	2.90%811.02M
Total liabilityies and equity	-2.92%892.45M	-1.66%881.04M	-1.81%944.72M	-2.86%930.41M	-0.68%919.27M	-0.58%895.93M	-1.73%962.18M	2.72%957.76M	4.20%925.6M	6.29%901.12M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

300519 Zhejiang Xinguang Pharmaceutical

Zhejiang Xinguang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target